“The new test system quickly detects the presence of a mutant strain, which is realized due to a special selection of oligonucleotides for effective amplification of the British mutation, and is designed for the maximum concentration of the virus. This avoids false positive results when detecting mutations for samples with a very high viral load”, – said in a message from the department.
TASS clarifies that the test has successfully passed all clinical trials, it has high accuracy and is already registered for use in Russia.
Source: Вести.Ru by www.vesti.ru.
*The article has been translated based on the content of Вести.Ru by www.vesti.ru. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!